Generic QoL assessment with the EQ5D was less sensitive than AFEQT, in differentiating C2 and C3 patients, although scores were lower in C2 patients (0.7; 0.4–0.82) compared with C3 (0.78; 0.62–0.8; p=0.056), this did not reach statistical significance ( figure 1E ). 10.1136/openhrt-2022-001969.supp3 Supplementary data To understand which aspect of AF was driving the clinical prioritisation between C2 and C3 patients, we analysed the three subgroups of AFEQT: symptoms, daily activities and concerns regarding treatment.
← all excerpts
Impact of COVID-19 on patients awaiting ablation for atrial fibrillation.
1
—
—